Abbott Laboratories (ABT), Millicom International Cellular (TIGO), Rain Oncology (RAIN), and NeoGames (NGMS) Face Rating Downgrades
- May 30th, 2023
- 685 views
Several companies have experienced downgrades in their ratings today:
Abbott Laboratories (NYSE: ABT), a well-known healthcare company, has been downgraded from Overweight to Equal-Weight by Morgan Stanley.
Currently, $ABT is trading at $101.70, reflecting a decline of $1.17 or 1.06%.
Millicom International Cellular S.A. (Nasdaq: TIGO), a telecommunications and media company operating primarily in Latin America, has experienced a downgrade from Overweight to Equal Weight by Barclays.
$TIGO is trading at $16.82 in intraday, indicating a decrease of $1.16 or 6.48%.
Rain Oncology Inc. (Nasdaq: RAIN), a biopharmaceutical company specializing in cancer therapies, has been downgraded from Buy to Neutral by ROTH MKM.
$RAIN is currently trading at $1.07, reflecting a decline of $0.02 or 2.27%.
NeoGames S.A. (Nasdaq: NGMS), a leading provider of online lottery and scratch games, has experienced a downgrade from Outperform to Neutral by Macquarie.
In intraday, $NGMS is trading at $27.20, down $0.07 or 0.24%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login